FENC Competitors & Alternatives
Compare Fennec Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
FENC
Main Stock$10.90
Tradestie Score
54
Market Cap
$266.91M
Revenue Growth
0.9%
Analyst Upside
+57.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$12.12
|
$407.71M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.58
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.11
|
$382.04M | - | 32 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.36
|
$371.64M | - | 50 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$10.24
|
$357.51M | - | 31 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$9.33
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$10.19
|
$354.45M | - | 43 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.46
|
$353.70M | - | 35 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.97
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.98
|
$328.62M | - | 28 | Compare |
More FENC Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry